Abacus Planning Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,400
Closed -$68K 197
2021
Q2
$68K Hold
10,400
0.02% 187
2021
Q1
$72K Hold
10,400
0.02% 184
2020
Q4
$106K Hold
10,400
0.03% 178
2020
Q3
$36K Hold
10,400
0.01% 170
2020
Q2
$52K Hold
10,400
0.02% 161
2020
Q1
$35K Hold
10,400
0.02% 154
2019
Q4
$57K Hold
10,400
0.03% 171
2019
Q3
$59K Hold
10,400
0.03% 167
2019
Q2
$80K Buy
+10,400
New +$56K 0.05% 157

Other funds holding PGEN

Abacus Planning Group's PGEN Position: Q3 2021 in Review

Abacus Planning Group sold out of Precigen (PGEN) in Q3 2021, closing a stake of 10,400 shares — an estimated $68K sold.

Abacus Planning Group first reported a position in PGEN in Q2 2019 and held it in 9 quarters. The position peaked at $106K in Q4 2020. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • Abacus Planning Group reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
  • Abacus Planning Group sold 10,400 Precigen shares in Q3 2021, an estimated $68K.
  • Abacus Planning Group first reported a position in Precigen in Q2 2019 and held it in 9 quarters.
  • Abacus Planning Group's Precigen position peaked at $106K in Q4 2020.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Abacus Planning Group's 13F filing for Q3 2021, filed 19 Oct 2021.